Jungsoon Lee

1 month ago | digitalcommons.library.tmc.edu | Syamala Rani Thimmiraju |Rakesh Adhikari |Maria Villar |Jungsoon Lee

Keywordsimmune escape, vaccine efficacy, COVID-19, SARS-CoV-2Abstract(1) Background: We previously reported the development of a recombinant protein SARS-CoV-2 vaccine, consisting of the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein, adjuvanted with aluminum hydroxide (alum) and CpG oligonucleotides.